Rachel Nuwer is a freelance science journalist who regularly contributes to The New York Times, Nature, Scientific American and more. Her latest book is “I Feel Love: MDMA and the Quest for Connection in a Fractured World.” She is also adjunct professor of science journalism at New York University.
Rachel Nuwer
Contributing writer
From this contributor
Lisa Croen: Autism’s first dedicated epidemiologist
Inspired by watching her autistic nephew grow up, Croen has also been an advocate for bolstering research and services for autistic adults.
Lisa Croen: Autism’s first dedicated epidemiologist
By
Rachel Nuwer
28 March 2022 | 9 min read
Finding strengths in autism
Autism comprises a set of difficulties, but growing evidence suggests that certain abilities also define the condition.
Meet the autistic scientists redefining autism research
Growing ranks of researchers on the spectrum are overcoming barriers — from neurotypical bias to sensory sensitivities — to shape autism science.
Meet the autistic scientists redefining autism research
By
Rachel Nuwer
10 June 2020 | 18 min read
Growing old with autism
For many autistic adults, the golden years are tarnished by poor health, poverty and, in some cases, homelessness. Their plight reveals huge gaps in care.
Mouse study links gene to some autism symptoms
Mice missing a gene called PTCHD1 in a deep-seated brain structure have autism-like symptoms that ease with treatment.
Explore more from The Transmitter
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
By
Kenneth Harris
9 July 2026 | 9 min read
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
By
Dalmeet Singh Chawla
8 July 2026 | 5 min read
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
Diverse autism genes derail common developmental pathways
Multiple genetic mouse models initially show delayed cortical development, but the animals’ molecular trajectories diverge within weeks after birth, a new study finds.
By
Holly Barker
8 July 2026 | 5 min read